Month: July 2020

TEMPE, Ariz., July 23, 2020 (GLOBE NEWSWIRE) — First Solar, Inc. (Nasdaq: FSLR) announced that Goldman Sachs Renewable Power LLC (GSRP), a private company managed by the Renewable Power Group of Goldman Sachs Asset Management (GSAM), acquired the 123-megawatt (MW)AC American Kings Solar project in a transaction that closed at the end of June 2020. Located in Kings County, California, the project is backed by a 15-year Power Purchase Agreement (PPA) with Southern California Edison and is scheduled to be commissioned in the fourth quarter of 2020.“We are excited to partner with First Solar and M&T Bank in acquiring the American Kings Solar project.  This is a bankable power plant backed by a long-term PPA, that is responsibly developed, and will generate the lowest carbon electricity possible today,” said Greg Roer, vice president,...

ATLANTA, July 23, 2020 (GLOBE NEWSWIRE) — Jacada, Inc., a pioneer of intelligent customer service automation, has announced its newest strategic partner, Symphony, a SYKES company, a global consulting and managed services firm that specializes in designing and deploying IA solutions that help clients rapidly realize the full potential of digitized operations.  They will be reselling and deploying Jacada’s full suite of contact center automation solutions worldwide.With Symphony, Jacada will support their clients’ RPA and IA initiatives with a trusted global leader in designing, implementing, and managing intelligent customer experiences. Together, Symphony and Jacada will leverage their mutual commitment to enabling customer service excellence through strategic and seamless end-to-end automation to provide their joint customers...

JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced changes in the composition of its board of directors that will take effect later this year.  Two of the Company’s directors will be leaving the board and, effective September 1, 2020, two new directors will be joining.The new board members are Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D.Dr. Buckle currently serves as Executive Vice-President of Technology Transfer and Industrial Partnership at Institut Pasteur in Paris, France. Previously, Dr. Buckle served as Global Vice President, Clinical Mass Spectrometry at Bruker Daltonics. Prior to that, she was CEO and Chairman of InGEN Biosciences (an in vitro diagnostics company...

Earnings Release: Monday, July 27, 2020, After Market Close Conference Call and Webcast: Tuesday, July 28, 2020, at 8:30 a.m. ETMONACO, July 23, 2020 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE), announced today that it will release its results for the second quarter ended June 30, 2020 after the market closes in New York on Monday, July 27, 2020.Conference Call Details:On Tuesday, July 28, 2020 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results.Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US), 0808-238-9064 (from the UK) or +1-412-317-9258 (from outside the US). Please quote “Costamare”.A replay of the conference call will be available until August 4, 2020. The United States replay...

GARDEN CITY, N.Y., July 23, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO for the treatment of solid tumors, today announced it will report financial results for its fiscal first quarter ended June 30, 2020 before the market opens on Thursday, August 6, 2020. The Company’s management team is scheduled to host a conference call and webcast at 8:30 a.m. Eastern Time.About Beyond Air, Inc.Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, the LungFit™, that uses NO generated from ambient air...

Golar Power Limited (“Golar Power”), a joint venture between Golar LNG Limited (NASDAQ ticker: GLNG) and Stonepeak Infrastructure Partners, is pleased to announce today the execution of a Memorandum of Understanding with Norsk Hydro to develop the first LNG terminal in the North of Brazil, a major step towards one of the largest greenhouse gas reduction initiatives, globally.The project will enable the supply of LNG to Norsk Hydro’s Alunorte refinery plant located close to the Vila do Conde Port in the Municipality of Barcarena, State of Pará, Brazil. Alunorte will also be the first operational customer for the Barcarena FSRU that Golar Power plans to bring into operation during the first half of 2022. Concluding final agreements with Norsk Hydro will therefore be an important step toward a Final Investment Decision within the next 4...

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2020 after the market closes on Thursday, August 6, 2020, and will host a conference call at 5:30 pm ET that day to discuss those results.To participate in the conference call, dial (877) 376-9925 (U.S. and Canada) or (629) 228-0732 (International) and use conference ID number 2649347. The call will also be available via live or archived webcast on the “Investor Relations” section of the Establishment Labs website at www.establishmentlabs.com.About Establishment LabsEstablishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused...

RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2020 after the close of trading on Thursday, July 30, 2020. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers. A live webcast of the event will be available in the “Investors” section of the company’s website at www.eksobionics.com, or by clicking here.A replay of the call will be available for two weeks by dialing 877-660-6853...

MUNCIE, Ind., July 23, 2020 (GLOBE NEWSWIRE) — First Merchants Corporation (NASDAQ – FRME) has reported second quarter 2020 net income of $33 million compared to $41.1 million during the same period in 2019.  Earnings per share for the period totaled $.62 per share compared to the second quarter of 2019 result of $.83 per share.  Year-to-date net income totaled $67.3 million compared to $79.9 million during the six months ended June 30, 2019.  Year-to-date earnings per share totaled $1.24 compared to $1.61 during the same period in 2019.Total assets equaled $13.8 billion as of the quarter-ended June 30, 2020 and loans totaled $9.3 billion.  The Corporation’s loan portfolio increased by $1.8 billion, or 23.7 percent, during the past twelve months.  Investments increased $696 million, or 33.3 percent, during the same period...

ANDOVER, Mass., July 23, 2020 (GLOBE NEWSWIRE) — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the second quarter after market close on Wednesday, August 5, 2020. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.Investors interested in listening to the conference call may do so by dialing (866) 221-1172 for domestic callers or (270) 215-9603 for international callers, followed by Conference ID: 9858896. A live and archived webcast of the event will be available on the “Investors” section of the TransMedics website at https://investors.transmedics.com/. About TransMedics...